Editas Medicine, Inc. EDIT
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2016-02-03
Chart by TradingView
1/9
Piotroski F — financial health
-29.91
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $40.5M | $32.3M | $78.1M | $19.7M | $25.5M |
| Operating income | -$160.0M | -$251.2M | -$169.2M | -$225.9M | -$193.1M |
| Net income | -$160.1M | -$237.1M | -$153.2M | -$220.4M | -$192.5M |
| Operating cash flow | -$165.2M | -$210.3M | -$132.2M | -$177.3M | -$163.8M |
| Free cash flow | -$165.8M | -$219.1M | -$136.9M | -$181.5M | -$171.8M |
| Total assets | $186.5M | $341.6M | $499.2M | $514.3M | $677.5M |
| Total liabilities | $159.2M | $207.3M | $150.1M | $153.6M | $123.8M |
| Shareholders' equity | $27.3M | $134.3M | $349.1M | $360.7M | $553.6M |
| Ratios | |||||
| Operating margin | -394.9% | -777.2% | -216.6% | -1146.3% | -756.1% |
| Net margin | -395.0% | -733.7% | -196.1% | -1118.3% | -753.6% |
| FCF margin | -409.3% | -678.1% | -175.2% | -920.6% | -672.5% |
| Return on assets | -85.8% | -69.4% | -30.7% | -42.9% | -28.4% |
| Return on equity | -586.6% | -176.6% | -43.9% | -61.1% | -34.8% |
| Debt / equity | 1.96× | 0.39× | 0.00× | — | — |
| Current ratio | 3.54 | 3.75 | 5.39 | 5.94 | 10.82 |
| Revenue growth | 25.4% | -58.6% | 296.3% | -22.8% | -71.8% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 3,972,160 | $9.8M |
| Point72 Asset Management, L.P. | 116,995 | $288,978 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -29.91 (distress)
- Working capital / assets 0.631
- Retained earnings / assets -8.73
- EBIT / assets -0.858
- Equity / liabilities 0.171
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001650664 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.